Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International Consensus.
Int J Radiat Oncol Biol Phys
2023
116
3
503-520
Combination of radiation and immunotherapy in the treatment of genitourinary malignancies: A systematic review and meta-analysis.
Urol Oncol
2023
41
5
219-232
Prognostic Role of 68Ga-PSMA11 PET-Based Response in Patients with Prostate Cancer Undergoing Taxane-Based Chemotherapy.
J Nucl Med
2023
64
6
896-901
177Lu-PSMA-I&T for Treatment of Metastatic Castration-Resistant Prostate Cancer: Prognostic Value of Scintigraphic and Clinical Biomarkers.
J Nucl Med
2023
64
3
402-409
Prostate cancer-related anxiety among long-term survivors after radical prostatectomy: A longitudinal study.
Cancer Med
2023
12
4
4842-4851
[Value of immunotherapy in the perioperative treatment of localized muscle invasive bladder cancer].
Urologie
2023
62
3
279-287
25 years International Bladder Cancer Network (IBCN): The past, the present, and the future.
Urol Oncol
2023
41
7
302-306
Unbiased chemokine receptor screening reveals similar efficacy of lymph node- and tumor-targeted T cell immunotherapy.
Cancer Immunol Immunother
2023
72
9
3111-3124
Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen-radioguided Surgery.
Eur Urol
2023
83
1
62-69